RBC Capital Maintains Outperform on Encompass Health, Raises Price Target to $95
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Ben Hendrix maintains an Outperform rating on Encompass Health (NYSE:EHC) and raises the price target from $83 to $95.
May 22, 2024 | 2:16 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
RBC Capital analyst Ben Hendrix maintains an Outperform rating on Encompass Health and raises the price target from $83 to $95.
The raised price target and maintained Outperform rating from a reputable analyst at RBC Capital is likely to positively influence investor sentiment and drive short-term price appreciation for Encompass Health.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100